Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Lindy Berkman, Daniel Bottomley et al.|The Lancet Oncology|2025Cited by 23
Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After ChemoradiotherapyKatie Wakeham, Duncan C. Gilbert, Louise Murray et al.|Clinical Oncology|2021Cited by 17
Standard Versus Dose Reduced Chemoradiotherapy in Anal Cancer: Short Term Results of the PhaseII PLATO-ACT4 Randomised Controlled Trial (RCT) ISRCTN88455282Alexandra Gilbert, Mark Harrison, Richard Adams et al.|SSRN Electronic Journal|2025Cited by 3